Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Common Risk Factors Include: Northern European descent Age over 50 years Autoimmune disorders (e.g., thyroid disease, type 1 diabetes) Long-term use of acid-suppressing medications Strict vegetarian or vegan diets History of gastric or intestinal surgery Pathophysiology of Pernicious Anemia The development of pernicious anemia follows a predictable sequence: Autoimmune destruction of gastric parietal cells Reduced or absent intrinsic factor production Failure to absorb vitamin B12 in the terminal ileum Impaired DNA synthesis in bone marrow Production of large, dysfunctional red blood cells Reduced oxygen-carrying capacity Over time, vitamin B12 deficiency also affects the nervous system , leading to neurological symptoms
Glucose-dependent Insulinotropic Peptide (GIP): GIP also helps regulate insulin levels and plays a role in fat metabolism
Small steps, careful observation and open conversation usually produce the clearest answers about whether a supplement is helping or should be stopped
SGLT2 inhibitors (empagliflozin, dapagliflozin): act on the kidney
Using the prescribed injection schedule ensures you receive consistent, safe medication delivery aligned with clinical research
.png)
